SUBJECT INDEX 



417 



5, 6-Dichloro-l-a-D-arabinopyranosyl- 



benzimidazole and 

 ferret nasal epithelium and, 69 

 filament formation and, 85 

 genetic recombination and, 229 

 growth of, 135-136 



hamster lung, adaptation and, 237-240 

 hemagglutination and, 22, 24, 25, 28 

 hemagglutinin of, 131 

 heterotypic influenza virus, interference 



between, 162, 173, 174 

 homologous, interference between, 175 

 lag period, recoverable infective virus 



and, 115, 116, 120, 123-124, 125 

 mouse lung, adaptation and, 237-240 

 mouse pneumonia virus, interference 



between, 162 

 mumps virus, interference between, 162, 



163, 175 

 Newcastle disease virus, interference 



between, 162, 163, 173 

 O-D change, virulence variation and, 



230-232 

 pentamidine and, 219 

 P phase, hemagglutination inhibition 



and, 268 

 Q phase, hemagglutination inhibition 



and, 268 

 ribonuclease, multiplication inhibition 



and, 276 

 recombination studies, virulence and, 159 

 release of, 139-140, 142, 214 

 R phase, hemagglutination inhibition 



and, 268 

 serological variation 



adaptation to new hosts and, 265-267 



during passage and, 265-269 



induced and, 267 



phase and, 267-269 



serological types and, 254 



Type A strains and, 254-265 



Type B strains and, 265 



viral structure and, 253-254 

 soluble antigen and, 126-129, 206-207 

 St. Louis encephalitis virus, interference 



between, 162, 163 

 structure of, 12 



vaccinia virus, interference between, 162 

 West Nile encephalitis virus, inter- 

 ference between, 162, 163 



VOL. Ill — 27 



Xerosin, host protection and, 159 

 yellow fever virus, interference between, 

 163 

 Inhibition 



chemical structure 



amino acids and, 217-218 

 benzimidazoles and, 214-217 

 oxidative metabolism and, 218-219 

 purine analogs and, 218 

 pyrimidine analogs and, 218 

 hemagglutinin, genetic marker and, 279 

 hemagglutination 



influenza A virus and, 256-258 

 phase influenza viruses and, 268 

 intracellular multiplication 

 5, 6-dichloro-l-a-D-arabinopyranosyl- 

 benzimidazole and, 203, 210-211, 

 212, 213, 216, 217 

 5, 6-dichloro-l-/?-D-ribofuranosylbenzi- 

 midazole and, 203, 206-209, 211, 

 212, 215-216, 217 

 2, 5-dimethylbenzimidazole and, 203 



205, 211, 212, 213 

 p-fluorophenylalanine and, 203, 209, 



211, 212, 218, 220 



Klebsiella pneumoniae capsular poly- 

 saccharide and, 203-205, 211, 212 



latent period and, 202-211 



levo -y-(o - chloro benzyl)- S -oxo-y - 

 phenyl caproic acid and, 203, 210 



212, 213 



DL-methoxinine and, 203, 205-206, 

 211,212,213,217 



post-latent period and, 211, 213 

 ribonuclease, influenza virus multiplica- 

 tion and, 276 

 virus multiplication, current status of, 



220-222 

 virus release and, 213-214 

 Inhibitors 



hemagglutination 



N-acetylglucosamine and, 53 



arboviruses and, 41^2 



Chu and, 35-36 



mucoid and, 33-34, 36-37, 52, 53 



specific antibody and, 34-35 

 Insect viruses, see also Polyhedral viruses. 



Granulosis viruses and individual 



insect species 

 cross transmission and, 386-388 



